| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/20/2001 | EP1108428A2 Compositions for and uses thereof for treating viral disease with phenylacetate and derivatives thereof |
| 06/20/2001 | EP1108427A2 Compositions for and uses thereof for altering gene expression with phenylacetate and derivatives thereof |
| 06/20/2001 | EP1108051A2 Inducible expression system |
| 06/20/2001 | EP1108049A2 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences |
| 06/20/2001 | EP1108048A1 Cationic complexes of polymer-modified adenovirus |
| 06/20/2001 | EP1108046A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 06/20/2001 | EP1108042A2 Molecules designated b7l-1 |
| 06/20/2001 | EP1108039A2 Elongase genes and uses thereof |
| 06/20/2001 | EP1108038A1 Superoxide dismutase as a vaccine antigen |
| 06/20/2001 | EP1108036A1 Dengue viruses that are replication defective in mosquitos for use as vaccines |
| 06/20/2001 | EP1108035A2 Treatment of cervical cancer |
| 06/20/2001 | EP1108033A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 06/20/2001 | EP1108029A1 Kunitz domain polypeptide zkun6 |
| 06/20/2001 | EP1108027A1 Hypertension associated transcription factor-1 (hatf-1) and and hatf related protein 1 (hrp-1) |
| 06/20/2001 | EP1108026A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 06/20/2001 | EP1108025A2 Phelix: a testis-specific protein expressed in cancer |
| 06/20/2001 | EP1108024A1 Lim domain protein homolog |
| 06/20/2001 | EP1108023A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 06/20/2001 | EP1108021A2 Human genes differentially expressed in colorectal cancer |
| 06/20/2001 | EP1108019A2 Protein transport-associated molecules |
| 06/20/2001 | EP1108018A1 Human deltex-like gene zdx |
| 06/20/2001 | EP1108016A2 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy |
| 06/20/2001 | EP1108015A1 Streptavidin mutants having secondary functional domains |
| 06/20/2001 | EP1108014A1 $i(EHRLICHIA CANIS) 120-KDA IMMUNODOMINANT ANTIGENIC PROTEIN AND GENE |
| 06/20/2001 | EP1108013A2 Genes associated with neurotransmitter processing |
| 06/20/2001 | EP1107996A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 06/20/2001 | EP1107992A2 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6 |
| 06/20/2001 | EP1107991A1 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120 |
| 06/20/2001 | EP1107989A2 Expression and export of angiostatin and endostatin as immunofusins |
| 06/20/2001 | EP1107988A2 Method for chromatographically purifying insulins |
| 06/20/2001 | EP1107987A2 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor |
| 06/20/2001 | EP1107986A1 Protein domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 and methods of making and using the same |
| 06/20/2001 | EP1107983A2 Benzodiazepine and benzothiazepine derivatives and hbsag peptides binding to annexins, their compositions and use |
| 06/20/2001 | EP1107982A1 REVERSIBLE BORONATE COMPLEXES OF 1,2-$i(CIS)-DIOL CYCLIC-PEPTIDES |
| 06/20/2001 | EP1107981A2 Ring modified cyclic peptide analogs |
| 06/20/2001 | EP1107980A1 CRYSTALLINE FORMS OF EtO 2?C-CH 2?-($i(R))Cgl-Aze-Pab-OH |
| 06/20/2001 | EP1107978A1 Secreted proteins and polynucleotides encoding them |
| 06/20/2001 | EP1107977A1 Ratc |
| 06/20/2001 | EP1107976A1 Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor |
| 06/20/2001 | EP1107969A2 Collections of compounds |
| 06/20/2001 | EP1107813A1 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers or covering structures |
| 06/20/2001 | EP1107797A2 Hypoxia regulated genes |
| 06/20/2001 | EP1107794A2 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 06/20/2001 | EP1107793A1 Dextran-leptin conjugates, pharmaceutical compositions and related methods |
| 06/20/2001 | EP1107791A2 Hydrogel compositions for the controlled release administration of growth factors |
| 06/20/2001 | EP1107790A1 Targeting of molecules to large vessel endothelium using epcr |
| 06/20/2001 | EP1107789A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/20/2001 | EP1107788A1 Scrp-5: secreted cysteine rich protein-5 |
| 06/20/2001 | EP1107784A2 Activation and protection of t-cells (cd4?+ and cd8?+ ) using an h 2? receptor agonist and other t-cell activating agents |
| 06/20/2001 | EP1107781A2 Treatment of lesions with xanthine oxidoreductase |
| 06/20/2001 | EP1107780A2 Selective treatment of endothelial somatostatin receptors |
| 06/20/2001 | EP1107779A2 Medicaments for manipulating t-cell immune response |
| 06/20/2001 | EP1107778A1 Treatment of disease states |
| 06/20/2001 | EP1107777A1 Stabilized pharmaceutical composition in lyophilized form |
| 06/20/2001 | EP1107774A1 Ramp2a: receptor activity modifying protein-2a |
| 06/20/2001 | EP1107770A2 Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders |
| 06/20/2001 | EP1107768A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | EP1107752A1 Pyrrolidine derivatives for vision and memory disorders |
| 06/20/2001 | EP1107751A2 Medicament containing platinum complex compounds and the use thereof |
| 06/20/2001 | EP1107749A2 The use of fumaric acid derivatives in transplant medicine |
| 06/20/2001 | EP1107743A1 Stable spray-dried protein formulations |
| 06/20/2001 | EP1107722A2 A method for the treatment of staphylococcal disease |
| 06/20/2001 | EP1107702A1 Ultrasonic enhancement of drug injection |
| 06/20/2001 | EP1071485A4 Revascularization apparatus having coaxial channeling and injection means |
| 06/20/2001 | EP1035780A4 Method for purifying heat shock peptides complexes |
| 06/20/2001 | EP0889902B1 Antibiotic peptides from bovine milk |
| 06/20/2001 | EP0768308B1 derivatives of pyroglutaminic acid, preparation process and applications |
| 06/20/2001 | EP0754194B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 06/20/2001 | EP0618962B1 Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis |
| 06/20/2001 | CN1300367A Methods and compositions for diagnosis of rheumatoid arthritis |
| 06/20/2001 | CN1300323A Recombinant (alpha)-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 06/20/2001 | CN1300295A Hybrid protein for inhibiting the deatanulation of mastocytes and the use thereof |
| 06/20/2001 | CN1300294A Frameshift mutants of beta-amyloid precursor protein and ubiquitin-B and their use |
| 06/20/2001 | CN1300224A Protease inhibitors in absorbent articles |
| 06/20/2001 | CN1300223A Disposable absorbent article having a skin care composition containing an enzyme inhibitor |
| 06/20/2001 | CN1300221A Treatment of cardiao hypertrophy |
| 06/20/2001 | CN1300220A Peptide compositions and formulations and use of same |
| 06/20/2001 | CN1300214A Composition comprising acarnitine and glutathione, useful to incrense the absorption of glutathione and synergize its effects |
| 06/20/2001 | CN1299826A Colored mistletoe herb glycoprotein extraction and its medicine composite and preparation |
| 06/20/2001 | CN1299682A Interferon spray |
| 06/20/2001 | CN1299681A Compound poultry lymphatic factor and its production process |
| 06/20/2001 | CN1067460C Pumping device |
| 06/20/2001 | CN1067276C Ointment for curing putrefactive wound, producing method and use thereof |
| 06/20/2001 | CN1067250C Neutral calcium-supplementary preparation |
| 06/20/2001 | CN1067223C Lactose-containing food composition for infants |
| 06/19/2001 | US6248903 Process for the preparation of methyl (2s)-2-[(3r)-3-(n-{tert-butyloxycarbonyl 9-amino)-2-oxopyrrolidin-1-yl]propionate |
| 06/19/2001 | US6248873 Nucleotide sequences associated with cardiovascular disorders; for the detection of genetic adjustment in the genome |
| 06/19/2001 | US6248872 Nucleotide sequences which code enzymatic protein; for use in detection and treatment of dirofilaria infection |
| 06/19/2001 | US6248867 Polypeptide associated with proper eye function; for the diagnosis of vision defects |
| 06/19/2001 | US6248865 Compounds useful for the synthesis of dolastatin analogs |
| 06/19/2001 | US6248864 Compounds and methods and modulating tissue permeability |
| 06/19/2001 | US6248775 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 06/19/2001 | US6248736 Dna polymerase inhibitors effective against herpesviruses |
| 06/19/2001 | US6248729 Combination of an ADP-receptor blocking antiplatelet drug and antihypertensive drug and a method for preventing a cerebral infarction employing such combination |
| 06/19/2001 | US6248725 Mixture comprising tri-iodothyronine (t3) and keratinocyte growth factor (kgf) in a pharmaceutically acceptable carrier administered in a dosage to induce in vivo a semi-synchronous wave of liver cell proliferation |
| 06/19/2001 | US6248724 Antisense oligonucleotide compositions targeted to angiotensin converting enzyme MRNA and methods of use |
| 06/19/2001 | US6248723 Method for treatment of inflammatory disease |
| 06/19/2001 | US6248722 Topically administering a dosage of an expression vector containing hepatocyte growth factor (hgf) gene; gene therapy with reduced side effects |
| 06/19/2001 | US6248717 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |